Status: Recruiting
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
Prospective, single-blinded, single-center, parallel group, randomized controlled trial (RCT) to assess rate and frequency of wound healing and associated financial savings, when using Medaxis debritom+ versus standard of care as a choice of debridement method, where both arms follow normal wound care practice in use of advanced wound care treatments.
Participants needed: 180
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medaxis, LLCUpdated: Nov 21, 2024Locations: 1
Eligibility criteria
At least 18 years old. [+10]
The index ulcer will be the largest ulcer if two or more VLUs are present and wi... [+28]